Microglia found to play a key role in regulating the body’s response to anesthesia

On Thurs­day, Eli Lil­ly dropped more da­ta for its once-week­ly in­sulin can­di­date in adults with type 2 di­a­betes. In two Phase 3 tri­als, dubbed QWINT

Turn­stone Bi­o­log­ics raised $80 mil­lion in a Fri­day morn­ing IPO un­der the tick­er $TS­BX, book­end­ing a rare two-week stretch for biotech list­ings. The start­up fol­lows